Navigation Links
EMBO announces the launch of EMBO Press
Date:10/29/2013

HEIDELBERG, 29 October 2013 EMBO today announced that it will launch EMBO Press on December 15. EMBO Press is a new publishing platform for The EMBO Journal, EMBO reports, Molecular Systems Biology and EMBO Molecular Medicine that provides opportunities for the future development of the journals.

EMBO Press will strengthen the policies of the EMBO journals to encourage transparency in the publication process and help researchers make better use of scientific data. In addition, The EMBO Journal, EMBO reports, Molecular Systems Biology and EMBO Molecular Medicine are being redesigned to maximize online functionality and access.

The announcement coincides with an expanded publishing agreement with Wiley and a new partnership with HighWire Press of Stanford University that come into immediate effect.

Wiley has published EMBO Molecular Medicine since 2009. As one of the world's leading publishers of academic content, it will provide invaluable support for editorial production and international marketing of the four EMBO scientific journals.

HighWire Press is at the forefront of digital scholarly publishing. Many leading journals in the life sciences rely on its community-based strengths and its track record for technological support and innovation, including access to third party developers.

"We welcome our publishing partners to support EMBO Press and appreciate the strengths they will bring for the key global markets of our journals, including the United States and Asia Pacific," said Bernd Pulverer, Head of Scientific Publications at EMBO. "Our individual journals already have strong recognition for quality in the scientific community established over 30 years since the launch of The EMBO Journal and our mandate is to serve the scientific community. EMBO Press will allow us to provide the independence we need to ensure that the EMBO Press portfolio of journals stay at the forefront of technological advances and delivers the best possible service to the research community. In particular, it will allow EMBO to continue our commitment to the principles of transparent, fast and fair publication in the life sciences while maintaining our reputation for selectivity and quality."

EMBO Press will include enhanced options for publishing source data, and rendering the data presented in figures more usable and discoverable. Researchers will be able to customize and optimize their reader experience. Restructuring the way papers are presented will obviate the need for a separate supplementary information section.

"Many exciting developments lie ahead in publishing and we want to have a platform that supports technological responsiveness and high-level support," added Pulverer. "Access to the Drupal tools integrated into the HighWire Press Open Platform creates new possibilities for innovation in areas like data presentation, semantic interlinking, article level metrics and mobile web interfaces. There will be many exciting technological developments in the future and we want our authors and readers to be in a position to benefit."

"After many years of fruitful collaboration with Nature Publishing Group, we have decided to collaborate with Wiley and HighWire to implement the EMBO Press platform. EMBO Press gives us the freedom and flexibility we need to realize our future plans for the journals," commented Maria Leptin, Director of EMBO. "All the financial benefits from our publishing activities will continue to support the activities of EMBO and the scientific community."


'/>"/>

Contact: Barry Whyte
communications@embo.org
49-622-188-91108
European Molecular Biology Organization
Source:Eurekalert

Related biology news :

1. Basis Extends Series B to more than $23 Million; Announces Mobile Veteran, Ethan Fassett, as VP of Product
2. Biocom Announces 2013 San Diego Mayoral Primary Endorsement
3. Trovagene Announces Abstracts to be Presented at Molecular Targets and Cancer Therapeutics Conference
4. Dr. Bradley Kurgis Announces Free Skin Rejuvenation Consultation
5. Extreme Peptide Announces that its EP Reward Points Program is Now Easier than Ever to Use
6. Prostate Cancer Foundation announces new urine test for prostate cancer available
7. EcoHealth Alliance announces new award from USAID to combat disease emergence and climate change
8. NIH announces awards to strengthen the biomedical research workforce
9. New York Genome Center announces the New York Stem Cell Foundation as an Associate Member
10. DiscoveRx Announces Launch of New Human Primary Cell-Based Panels for Oncology Research
11. Entomological Society of America announces 2013 awardees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... June 27, 2016   Ginkgo Bioworks , a ... engineering, was today awarded as one of the ... the world,s most innovative companies. Ginkgo Bioworks is ... the real world in the nutrition, health and ... directly with customers including Fortune 500 companies to ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Researchers at the ... commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject ... it now. , Diagnostic biomarkers are signposts in the blood, lung fluid or ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
Breaking Biology Technology: